GrowingStockReport.com

Medivation, Inc. (NASDAQ:MDVN) and Celsion Corp. (NASDAQ:CLSN) Added to Growing Stock Report's NASDAQ Decliners Watch List.

 

New York, NY -- (ReleaseWire) -- 06/17/2013 -- Growing Stock Report expands its NASDAQ Decliners Weekly Watch List adding Medivation, Inc. (NASDAQ:MDVN) and Celsion Corp. (NASDAQ:CLSN).

Medivation, Inc. (NASDAQ:MDVN) a biopharmaceutical company that focuses on development and commercialization of novel therapies to treat serious diseases in the United States is currently down (-9.99%) on 2,292,232 shares traded. Medivation, Inc. (NASDAQ:MDVN) is currently down (-21.2%) from its recent 52-week high which has prompted Growing Stock Report to add the stock to their NASDAQ Decliners Watch List.

Click Here to find out what other Investors are saying about Medivation, Inc. (NASDAQ:MDVN)

Celsion Corp. (NASDAQ:CLSN) an oncology drug development company that focuses on the development and commercialization of targeted chemotherapeutic oncology drugs based on its proprietary heat-activated liposomal technology is currently down (-8.46%) on 4,075,376 shares traded after The Rosen Law Firm Announced Investigation of Securities Claims Against Celsion Corporation. Celsion Corp. (NASDAQ:CLSN) is currently down (-88.14%) from its recent 52-week high which has prompted Growing Stock Report to add the stock to their NASDAQ Decliners Watch List.

Click Here to find out what other Investors are saying about Celsion Corp. (NASDAQ:CLSN)

GrowingStockReport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities.

Through a vast network of IR professionals GrowingStockReport.com is often aware of several large investor awareness campaigns being deployed.

Timing is important when trading Small Caps and Penny Stocks.

Simply sign up for free and start receiving exclusive alerts.

Subscribe Here: http://www.GrowingStockReport.com

Disclosure: GrowingStockReport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit GrowingStockReport.com website, for complete risks and disclosures.

Contact Info:
Growing Stock Report
editor@GrowingStockReport.com